SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (476)2/7/1999 9:37:00 PM
From: Jongmans  Read Replies (1) of 4474
 
To Dr de Castro,

No. You are not right. It will be 100%

Besides the issuance of shares to HMR there are two other payments of them:

1 the osteoporosis collaboration. Mr LaMarche told me some weeks ago, that this collaboration continues.

2.the payment to ARIAD by the joint venture, due for services rendered to this joint venture. Half of that is payed effectively by HMR.

Total revenue from these sources during the third quarter $ 3,658 mln. In such amount, which will be comparable between Novemmber 12 1998 and February 15 1999, is certainly included the additional needed $ 1,3 mln to make the $ 7mln full.

Martin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News